| ||||||||||||||||||||||
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease Files in this Data Supplement:
Rheumatology
Isenberg et al. 43 (1): 49.
Supplementary Data
| ||||||||||||||||||||||